DPP—4抑制剂对2型糖尿病患者肾脏的保护作用(3)
参考文献
[1] Drucker D J.The role of gut hormones in glucose homeostasis[J].J Clin Invest，2007，117(1)：24-32.
[2] Yang J，Campitelli J，Hu G，et al.Increase in DPP-IV in the intestine，liver and kidney of the rat treated with high fat diet and streptozotocin[J].Life Sci，2007，81(4)：272-279.
[3] Feriozzi S，Germain D P，Di V R，et al.Cystatin C as a marker of early changes of renal function in Fabry nephropathy[J].J Nephrol，2007，20(4)：437-443.
[4] Tuttle K R，Bakris G L，Toto R D，et al.The effect of ruboxistaurin on nephropathy in type 2 diabetes[J].Diabetes Care，2005，28(11)：2686-2690.
[5] Sakata K，Hayakawa M，Yano Y，et al.Efficacy of alogliptin，a dipeptidyl peptidase-4 inhibitor，on glucose parameters， the activity of the advanced glycation end product (AGE)-receptor for AGE (RAGE) axis and albuminuria in Japanese type 2 diabetes[J].Diabetes Metab Res Rev，2013，29(8)：624-630.
[6] Rieg T，Gerasimova M，Murray F，et al.Natriuretic effect by exendin-4， but not the DPP-4 inhibitor alogliptin， is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice[J].Am J Physiol Renal Physiol，2012，303(7)：F963-971.
[7] Fadini G P，Boscaro E，Albiero M，et al.The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes： possible role of stromal-derived factor-1alpha[J].Diabetes Care，2010，33(7)：1607-1609.
(收稿日期：2016-02-13), 百拇医药(兰立强 闫作惠)
[1] Drucker D J.The role of gut hormones in glucose homeostasis[J].J Clin Invest，2007，117(1)：24-32.
[2] Yang J，Campitelli J，Hu G，et al.Increase in DPP-IV in the intestine，liver and kidney of the rat treated with high fat diet and streptozotocin[J].Life Sci，2007，81(4)：272-279.
[3] Feriozzi S，Germain D P，Di V R，et al.Cystatin C as a marker of early changes of renal function in Fabry nephropathy[J].J Nephrol，2007，20(4)：437-443.
[4] Tuttle K R，Bakris G L，Toto R D，et al.The effect of ruboxistaurin on nephropathy in type 2 diabetes[J].Diabetes Care，2005，28(11)：2686-2690.
[5] Sakata K，Hayakawa M，Yano Y，et al.Efficacy of alogliptin，a dipeptidyl peptidase-4 inhibitor，on glucose parameters， the activity of the advanced glycation end product (AGE)-receptor for AGE (RAGE) axis and albuminuria in Japanese type 2 diabetes[J].Diabetes Metab Res Rev，2013，29(8)：624-630.
[6] Rieg T，Gerasimova M，Murray F，et al.Natriuretic effect by exendin-4， but not the DPP-4 inhibitor alogliptin， is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice[J].Am J Physiol Renal Physiol，2012，303(7)：F963-971.
[7] Fadini G P，Boscaro E，Albiero M，et al.The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes： possible role of stromal-derived factor-1alpha[J].Diabetes Care，2010，33(7)：1607-1609.
(收稿日期：2016-02-13), 百拇医药(兰立强 闫作惠)